HLS Therapeutics Inc. (FRA:74D)
Germany · Delayed Price · Currency is EUR 2.860
+0.020 (0.70%)
At close: Dec 1, 2025
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of €94.48 million as of December 1, 2025. Its market cap has increased by 35.56% in one year.
Market Cap
94.48M
Enterprise Value
131.59M
Revenue
47.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.86
Market Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 197.81M to 94.48M, a decrease of -52.24%. That is a compound annual growth rate of -9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 95.75M | 14.16% |
| Dec 31, 2024 | 83.88M | -3.35% |
| Dec 29, 2023 | 86.78M | -60.57% |
| Dec 30, 2022 | 220.08M | -34.93% |
| Dec 31, 2021 | 338.22M | -7.74% |
| Dec 31, 2020 | 366.59M | -32.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |